Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15064 | 29113135 | Nutrients | Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15065 | 29113028 | Hepatology | Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis. | 2018 | Details |
| A15072 | 29108214 | Zhonghua Gan Zang Bing Za Zhi | [Association between intestinal flora imbalance and nonalcoholic fatty liver disease]. | 2017 | Details |
| A15082 | 29106066 | J Dig Dis | Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence. | 2017 | Details |
| A15090 | 29101772 | Rom J Intern Med | Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth. | 2018 | Details |
| A15092 | 29100781 | Steroids | Estrogens and female liver health. | 2017 | Details |
| A15107 | 29090980 | J Med Food | Dolichos lablab Protects Against Nonalcoholic Fatty Liver Disease in Mice Fed High-Fat Diets. | 2017 | Details |
| A15110 | 29089934 | Front Microbiol | Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver. | 2017 | Details |
| A15130 | 29083037 | Aliment Pharmacol Ther | Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. | 2017 | Details |
| A15135 | 29080343 | Ann Hepatol | Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and therapeutic advances. | 2017 | Details |
| A15136 | 29080046 | Curr Gastroenterol Rep | The Microbiome That Shapes Us: Can It Cause Obesity? | 2017 | Details |
| A15144 | 29075899 | J Gastroenterol | Immunoglobulin A and liver diseases. | 2017 | Details |
| A15162 | 29066788 | Sci Rep | Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism. | 2017 | Details |
| A15163 | 29066462 | Am J Physiol Endocrinol Metab | Genetic ablation of Cyp8b1 preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition. | 2017 | Details |
| A15218 | 29039050 | Pediatr Surg Int | The protective effect of fish oil lipid emulsions on intestinal failure-associated liver disease in a rat model of short-bowel syndrome. | 2017 | Details |
| A15219 | 29038503 | Nat Commun | Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. | 2017 | Details |
| A15227 | 29035368 | Nat Med | Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis. | 2017 | Details |
| A15228 | 29035308 | Nutrients | Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. | 2017 | Details |
| A15230 | 29034439 | Indian J Gastroenterol | Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture. | 2017 | Details |
| A15241 | 29027424 | Zhongguo Zhong Yao Za Zhi | [Research progress on therapeutic targets of active components in Chinese herbs for treatment of nonalcoholic fatty liver disease]. | 2017 | Details |
| A15243 | 29025734 | Am J Physiol Gastrointest Liver Physiol | Dietary copper-fructose interactions alter gut microbial activity in male rats. | 2017 | Details |
| A15256 | 29022143 | Neurol Sci | Comorbidity of gastrointestinal disorders, migraine, and tension-type headache: a cross-sectional study in Iran. | 2017 | Details |
| A15273 | 28990516 | Curr Med Chem | Gut Microbiota as a Therapeutic Target for Metabolic Disorders. | 2018 | Details |
| A15275 | 28990215 | J Ultrasound Med | Ultrasonic Perfluorohexane-Loaded Monocyte Imaging: Toward a Minimally Invasive Technique for Selective Detection of Liver Inflammation in Fatty Liver Disease. | 2017 | Details |
| A15282 | 28988228 | J Pediatr Endocrinol Metab | The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents. | 2017 | Details |
| A15288 | 28986308 | Biochim Biophys Acta Mol Basis Dis | n-3 Fatty acids combined with flavan-3-ols prevent steatosis and liver injury in a murine model of NAFLD. | 2017 | Details |
| A15305 | 28972878 | Discov Med | Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease. | 2017 | Details |
| A15313 | 28970836 | Front Immunol | Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease. | 2017 | Details |
| A15325 | 28966079 | Trends Endocrinol Metab | Multifunctional p62 Effects Underlie Diverse Metabolic Diseases. | 2017 | Details |
| A15327 | 28965313 | Obes Surg | Significant Liver-Related Morbidity After Bariatric Surgery and Its Reversal-a Case Series. | 2018 | Details |
| A15336 | 31966406 | Int J Clin Exp Pathol | High incidence of non-alcoholic fatty liver disease in patients with Crohn's disease but not ulcerative colitis. | 2017 | Details |
| A15352 | 28951310 | Gene | Glucose regulated protein 78 is potentially an important player in the development of nonalcoholic steatohepatitis. | 2017 | Details |
| A15376 | 28939830 | Sci Rep | Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. | 2017 | Details |
| A15378 | 28938455 | J Clin Endocrinol Metab | Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects. | 2017 | Details |
| A15396 | 28931589 | J Nutr | Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice. | 2017 | Details |
| A15405 | 28927250 | Minerva Gastroenterol Dietol | Gut microbiota and the liver. | 2017 | Details |
| A15406 | 28927249 | Minerva Gastroenterol Dietol | Gut microbiota, obesity and metabolic disorders. | 2017 | Details |
| A15422 | 28921469 | Adv Exp Med Biol | Microbial Factors in Inflammatory Diseases and Cancers. | 2017 | Details |
| A15439 | 28906444 | Nutrients | Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment. | 2017 | Details |
| A15442 | 28905102 | Arch Dermatol Res | Digestive system in psoriasis: an update. | 2017 | Details |
| A15454 | 28899857 | Am J Physiol Endocrinol Metab | High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine. | 2017 | Details |
| A15483 | 28880885 | PLoS One | Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children. | 2017 | Details |
| A15495 | 28876011 | Food Funct | A study of the prebiotic-like effects of tomato juice consumption in rats with diet-induced non-alcoholic fatty liver disease (NAFLD). | 2017 | Details |
| A15498 | 28875318 | Eur J Nutr | Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis. | 2017 | Details |
| A15501 | 28874313 | Gastroenterol Hepatol | New therapeutic perspectives in non-alcoholic steatohepatitis. | 2017 | Details |
| A15540 | 28852648 | Biomed Res Int | Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease. | 2017 | Details |
| A15565 | 28840809 | Microbiol Spectr | Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile. | 2017 | Details |
| A15566 | 28840806 | Microbiol Spectr | Microbiota, Liver Diseases, and Alcohol. | 2017 | Details |
| A15596 | 28823367 | Hepatobiliary Pancreat Dis Int | Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15616 | 28807841 | Gastroenterology | Racial Disparity in Gastrointestinal Cancer Risk. | 2017 | Details |
| A15631 | 28799803 | Crit Rev Food Sci Nutr | Nutrition, inflammation and liver-spleen axis. | 2017 | Details |
| A15656 | 28777914 | Can J Physiol Pharmacol | Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption. | 2017 | Details |
| A15671 | 28774887 | Gut | Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD. | 2017 | Details |
| A15672 | 28774869 | Am J Physiol Gastrointest Liver Physiol | Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis. | 2017 | Details |
| A15681 | 28767077 | Children (Basel) | Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15704 | 28751453 | J Endocrinol | Maternal modifiers of the infant gut microbiota: metabolic consequences. | 2017 | Details |
| A15751 | 28728746 | Am J Pathol | Linking Sex Differences in Non-Alcoholic Fatty Liver Disease to Bile Acid Signaling, Gut Microbiota, and High Fat Diet. | 2017 | Details |
| A15764 | 28722242 | Diabetes Obes Metab | Therapeutic application of GPR119 ligands in metabolic disorders. | 2017 | Details |
| A15777 | 28714405 | Curr Pharm Des | Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter. | 2017 | Details |
| A15796 | 28705785 | Turk J Gastroenterol | Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis. | 2017 | Details |
| A15829 | 28691342 | Mol Nutr Food Res | Dual function of Lactobacillus kefiri DH5 in preventing high-fat-diet-induced obesity: direct reduction of cholesterol and upregulation of PPAR-α in adipose tissue. | 2017 | Details |
| A15898 | 28663676 | J Clin Exp Hepatol | Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? | 2017 | Details |
| A15920 | 28652650 | World J Gastroenterol | Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. | 2017 | Details |
| A15924 | 28650209 | Expert Rev Gastroenterol Hepatol | The intestinal barrier: a fundamental role in health and disease. | 2017 | Details |
| A15947 | 28640662 | Gut Microbes | Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. | 2017 | Details |
| A15971 | 28632732 | PLoS One | Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis. | 2017 | Details |
| A15973 | 28632181 | Nutrients | Spirulina Protects against Hepatic Inflammation in Aging: An Effect Related to the Modulation of the Gut Microbiota? | 2017 | Details |
| A15995 | 28621554 | Expert Rev Gastroenterol Hepatol | Gut microbiota changes and chronic hepatitis C virus infection. | 2017 | Details |
| A16017 | 28609252 | Gut Microbes | Fecal microbiota transplantation in metabolic syndrome: History, present and future. | 2017 | Details |
| A16023 | 28605664 | J Nutr Biochem | Soy compared with milk protein in a Western diet changes fecal microbiota and decreases hepatic steatosis in obese OLETF rats. | 2017 | Details |
| A16025 | 28604704 | Nat Med | Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling. | 2017 | Details |
| A16030 | 28600319 | Physiol Genomics | Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification. | 2017 | Details |
| A16057 | 28591070 | J Clin Gastroenterol | Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015). | 2017 | Details |
| A16079 | 28580850 | Orv Hetil | [Advances in the pathogenesis of non alcoholic fatty liver disease]. | 2017 | Details |
| A16094 | 28573213 | ACS Cent Sci | Chemoproteomic Profiling of Bile Acid Interacting Proteins. | 2017 | Details |
| A16123 | 28551086 | Redox Biol | HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease. | 2017 | Details |
| A16125 | 28550391 | Hepatol Int | Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. | 2017 | Details |
| A16134 | 28545368 | Curr Med Chem | Improving Metabolic Control Through Functional Foods. | 2019 | Details |
| A16145 | 28539915 | Front Microbiol | The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease. | 2017 | Details |
| A16158 | 28533304 | J Lipid Res | Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids. | 2017 | Details |
| A16174 | 28521872 | Metabolism | Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. | 2017 | Details |
| A16225 | 28501229 | Prim Care | Integrative Medicine for Gastrointestinal Disease. | 2017 | Details |
| A16229 | 28497760 | Lancet Gastroenterol Hepatol | The intestinal microbiome and paediatric liver disease. | 2017 | Details |
| A16237 | 28492501 | Nutrients | Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations. | 2017 | Details |
| A16238 | 28490707 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | [Effect of NF-κB on the pathogenic course of non-alcoholic fatty liver disease]. | 2017 | Details |
| A16247 | 28484247 | Sci Rep | Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. | 2017 | Details |
| A16267 | 28478385 | J Biol Chem | Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism. | 2017 | Details |
| A16280 | 28471945 | AIDS | Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver. | 2017 | Details |
| A16306 | 28467925 | Cell Metab | Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16314 | 28464257 | Aliment Pharmacol Ther | Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A16315 | 28463404 | Mol Nutr Food Res | A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiota. | 2017 | Details |
| A16342 | 28446519 | Diabetes | Cationic Polystyrene Resolves Nonalcoholic Steatohepatitis, Obesity, and Metabolic Disorders by Promoting Eubiosis of Gut Microbiota and Decreasing Endotoxemia. | 2017 | Details |
| A16369 | 28434046 | Amino Acids | Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis. | 2017 | Details |
| A16370 | 28432400 | Internist (Berl) | [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis]. | 2017 | Details |
| A16372 | 28430371 | APMIS | Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease. | 2017 | Details |
| A16381 | 28426878 | Carcinogenesis | Microbiota, NASH, HCC and the potential role of probiotics. | 2017 | Details |
| A16395 | 28419855 | Clin Gastroenterol Hepatol | A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis. | 2017 | Details |
| A16402 | 28416740 | Oncotarget | Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease. | 2017 | Details |
| A16405 | 28414763 | PLoS One | Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations. | 2017 | Details |
| A16412 | 28411170 | Biochim Biophys Acta Biomembr | The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. | 2017 | Details |